557 related articles for article (PubMed ID: 28241742)
1. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
[TBL] [Abstract][Full Text] [Related]
2. Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects.
Sheikh N; Cham J; Zhang L; DeVries T; Letarte S; Pufnock J; Hamm D; Trager J; Fong L
Cancer Res; 2016 Jul; 76(13):3711-8. PubMed ID: 27216195
[TBL] [Abstract][Full Text] [Related]
3. Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.
Gkazi AS; Margetts BK; Attenborough T; Mhaldien L; Standing JF; Oakes T; Heather JM; Booth J; Pasquet M; Chiesa R; Veys P; Klein N; Chain B; Callard R; Adams SP
Front Immunol; 2018; 9():2547. PubMed ID: 30455696
[TBL] [Abstract][Full Text] [Related]
4. ImmunoDataAnalyzer: a bioinformatics pipeline for processing barcoded and UMI tagged immunological NGS data.
Vetter J; Schaller S; Heinzel A; Aschauer C; Reindl-Schwaighofer R; Jelencsics K; Hu K; Oberbauer R; Winkler SM
BMC Bioinformatics; 2022 Jan; 23(1):21. PubMed ID: 34991455
[TBL] [Abstract][Full Text] [Related]
5. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains.
Kitaura K; Shini T; Matsutani T; Suzuki R
BMC Immunol; 2016 Oct; 17(1):38. PubMed ID: 27729009
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing.
Thapa DR; Tonikian R; Sun C; Liu M; Dearth A; Petri M; Pepin F; Emerson RO; Ranger A
Arthritis Res Ther; 2015 May; 17(1):132. PubMed ID: 26001779
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
Li N; Yuan J; Tian W; Meng L; Liu Y
Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
[TBL] [Abstract][Full Text] [Related]
8. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.
Looney TJ; Topacio-Hall D; Lowman G; Conroy J; Morrison C; Oh D; Fong L; Zhang L
Front Immunol; 2019; 10():2985. PubMed ID: 31993050
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
10. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
[TBL] [Abstract][Full Text] [Related]
12. Overview of methodologies for T-cell receptor repertoire analysis.
Rosati E; Dowds CM; Liaskou E; Henriksen EKK; Karlsen TH; Franke A
BMC Biotechnol; 2017 Jul; 17(1):61. PubMed ID: 28693542
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor.
Ji S; Li J; Chang L; Zhao C; Jia R; Tan Z; Liu R; Zhang Y; Li Y; Yin G; Guan Y; Xia X; Yi X; Xu J
Clin Transl Oncol; 2021 Aug; 23(8):1646-1656. PubMed ID: 33583004
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
[TBL] [Abstract][Full Text] [Related]
15. Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.
Cham J; Zhang L; Kwek S; Paciorek A; He T; Fong G; Oh DY; Fong L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32376721
[TBL] [Abstract][Full Text] [Related]
16. A Framework for Annotation of Antigen Specificities in High-Throughput T-Cell Repertoire Sequencing Studies.
Pogorelyy MV; Shugay M
Front Immunol; 2019; 10():2159. PubMed ID: 31616409
[TBL] [Abstract][Full Text] [Related]
17. TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood.
Amoriello R; Chernigovskaya M; Greiff V; Carnasciali A; Massacesi L; Barilaro A; Repice AM; Biagioli T; Aldinucci A; Muraro PA; Laplaud DA; Lossius A; Ballerini C
EBioMedicine; 2021 Jun; 68():103429. PubMed ID: 34127432
[TBL] [Abstract][Full Text] [Related]
18. TCR diversity - a universal cancer immunotherapy biomarker?
McNeel DG
J Immunother Cancer; 2016; 4():69. PubMed ID: 27879971
[TBL] [Abstract][Full Text] [Related]
19. Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing.
Peng K; Nowicki TS; Campbell K; Vahed M; Peng D; Meng Y; Nagareddy A; Huang YN; Karlsberg A; Miller Z; Brito J; Nadel B; Pak VM; Abedalthagafi MS; Burkhardt AM; Alachkar H; Ribas A; Mangul S
Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37291798
[TBL] [Abstract][Full Text] [Related]
20. Analysis of TCR β CDR3 sequencing data for tracking anti-tumor immunity.
Zhang J; Ji Z; Smith KN
Methods Enzymol; 2019; 629():443-464. PubMed ID: 31727253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
